Seymour June Ann 🟢 acquired 25.5K shares (1 derivative) of Cartesian Therapeutics, Inc. (RNAC) at $6.76 Transaction Date: Jan 02, 2026 | Filing ID: 000034
Davis Blaine 🟢 acquired 146.0K shares (1 derivative) of Cartesian Therapeutics, Inc. (RNAC) at $6.76 Transaction Date: Jan 02, 2026 | Filing ID: 000033
Wyrick Susan D. 🟡 adjusted position in 2.4K shares (1 derivative) of Sana Biotechnology, Inc. (SANA) at $4.27 Transaction Date: Jan 02, 2026 | Filing ID: 000002
Director BARABE TIMOTHY C 🟢 acquired 10.4K shares (1 derivative) of Cartesian Therapeutics, Inc. (RNAC) at $6.76 Transaction Date: Jan 02, 2026 | Filing ID: 000032
English Emily 🟢 acquired 95.0K shares (1 derivative) of Cartesian Therapeutics, Inc. (RNAC) at $6.76 Transaction Date: Jan 02, 2026 | Filing ID: 000031
Director Thompson Craig B. 🟢 acquired 2.1K shares (1 derivative) of REGENERON PHARMACEUTICALS, INC. (REGN) at $772.76 ($1.5M) Transaction Date: Jan 02, 2026 | Filing ID: 000001
Director Singer Michael 🟢 acquired 10.4K shares (1 derivative) of Cartesian Therapeutics, Inc. (RNAC) at $6.76 Transaction Date: Jan 02, 2026 | Filing ID: 000030
Director SPRINGER TIMOTHY A 🟢 acquired 10.4K shares (1 derivative) of Cartesian Therapeutics, Inc. (RNAC) at $6.76 Transaction Date: Jan 02, 2026 | Filing ID: 000029
Director Kalayoglu Murat 🟢 acquired 10.4K shares (1 derivative) of Cartesian Therapeutics, Inc. (RNAC) at $6.76 Transaction Date: Jan 02, 2026 | Filing ID: 000028